---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-031312"
form_type: "8-K/A"
ticker: "FTLF"
cik: "0001374328"
company_name: "FITLIFE BRANDS, INC."
filed_at: "2025-10-20T23:59:59+00:00"
generated_at: "2026-05-17T03:11:57.515996+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# FitLife Brands files financials for acquired Irwin Naturals supplement business; $42.5M deal closed Aug 8, 2025

## Summary
- Total purchase price of $42.5M in cash; no earnouts or contingent consideration; acquired assets $50.8M, assumed liabilities $8.3M.
- Acquired business generated revenue of $67.9M in 2024 and $69.7M in 2023; excess of revenue over direct expense was $6.3M in 2024 vs. ($4.4M) in 2023.
- Provisional intangible assets of $31.8M: $25.5M for customer relationships and brands, $6.3M goodwill; subject to adjustment within one-year measurement period.
- Acquisition was approved by U.S. Bankruptcy Court for Central District of California under Section 363 of Bankruptcy Code.
- Pro forma condensed combined financial statements for FitLife and the acquired business as of June 30, 2025, and for FY2024 and H1 2025 are included.

## SEC filing metadata
- accession: 0001437749-25-031312
- form_type: 8-K/A
- ticker: FTLF
- cik: 0001374328
- company_name: FITLIFE BRANDS, INC.
- filed_at: 2025-10-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374328/000143774925031312/0001437749-25-031312-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374328/000143774925031312/ftlf20251012_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-031312
- JSON: https://secwatch.observer/filing/0001437749-25-031312.json
- Plain text: https://secwatch.observer/filing/0001437749-25-031312.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
